Hideto Nakajima

Prof. Hideto Nakajima

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
MTMuneyoshi Tagami
Muneyoshi Tagami
FKFumiharu Kimura
Fumiharu Kimura
HNHideto Nakajima
Hideto Nakajima
SIShimon Ishida
Shimon Ishida
SFShinya Fujiwara
Shinya Fujiwara
THToshiaki Hanafusa
Toshiaki Hanafusa

18 June 2010 in BMC Neurology
Verified
Journal Article
Open access
PDF file
HNHideto Nakajima
Hideto Nakajima
THTakafumi Hosokawa
Takafumi Hosokawa
MSMasakazu Sugino
Masakazu Sugino
FKFumiharu Kimura
Fumiharu Kimura
JSJun Sugasawa
Jun Sugasawa
TTToshiyuki Takahashi
Toshiyuki Takahashi
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that predominantly affects the optic nerves and the spinal cord, and is possibly mediated by an immune mechanism distinct from that of multiple sclerosis (MS). Central scotoma is recognized as a characteristic visual field defect pattern of optic neuritis (ON), however, the differing pathogenic mechanisms of NMO and MS may result in different patterns of visual field defects for ON.

19 April 2017 in BMC Neurology
Verified
Journal Article
Open access
PDF file
YNYoshitsugu Nakamura
Yoshitsugu Nakamura
HNHideto Nakajima
Hideto Nakajima
HTHiroki Tani
Hiroki Tani
THTakafumi Hosokawa
Takafumi Hosokawa
SIShimon Ishida
Shimon Ishida
INIchiro Nakashima
Ichiro Nakashima
Anti-Myelin oligodendrocyte glycoprotein (MOG) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (ADEM), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. We present a patient who developed anti-MOG antibody-positive ADEM following infectious mononucleosis (IM) due to Epstein–Barr virus (EBV) infection. A 36-year-old healthy man developed paresthesia of bilateral lower extremities and urinary retention 8 days after the onset of IM due to primary EBV infection. The MRI revealed the lesions in the cervical spinal cord, the conus medullaris, and the internal capsule. An examination of the cerebrospinal fluid revealed pleocytosis. Cell-based immunoassays revealed positivity for anti-MOG antibody with a titer of 1:1024 and negativity for anti-aquaporin-4 antibody. His symptoms quickly improved after steroid pulse therapy followed by oral betamethasone. Anti-MOG antibody titer at the 6-month follow-up was negative. This case suggests that primary EBV infection would trigger anti-MOG antibody-positive ADEM. Adult ADEM patients can be positive for anti-MOG antibody, the titers of which correlate well with the neurological symptoms.

31 May 2012 in The Open Neurology Journal
Verified
Journal Article
Open access
HNHideto Nakajima
Hideto Nakajima
KUKi-Ichi Unoda
Ki-Ichi Unoda
TITakumi Ito
Takumi Ito
HKHaruko Kitaoka
Haruko Kitaoka
FKFumiharu Kimura
Fumiharu Kimura
THToshiaki Hanafusa
Toshiaki Hanafusa
Background: Oxidative stress/free radical generation after ischemic stroke contributes to neuronal cell injury. We evaluated the utility of an oxidative stress marker, urinary 8-hydroxy-2-deoxyguanosine (8-OHdG), to demonstrate an association between the changes of 8-OHdG and outcomes after acute ischemic stroke. Methods: We enrolled 44 patients (26 males and 18 females) who visited our hospital due to acute ischemic stroke. Urine was collected on admission and on Days 7, and 8-OHdG was measured by ELISA. The relationships between 8-OHdG levels, stroke subtypes, and clinical outcomes based on the NIHSS and modified Rankin Scale (mRS) upon discharge was evaluated. Results: In the overall cohort, the mean urinary level of 8-OHdG on Day 7 was increased than that on Day 0. The 8-OHdG levels on Day 0 were not different between patients with poor and good outcomes. However, an increasing rate from Day 0 to 7 (Δ 8-OHdG) in stroke patients with a poor outcome(mRS ≥3) was significantly higher than those with a good outcome (mRS ≤2) (2.54 vs 39.44, p = 0.004). Conclusions: The biochemical changes related to 8-OHdG and oxidative stress may be considered a marker of ischemic brain injury and clinical outcome of ischemic stroke.

1 April 2018 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
HNHideto Nakajima
Hideto Nakajima
YNYoshitsugu Nakamura
Yoshitsugu Nakamura
YIYuiko Inaba
Yuiko Inaba
CTChiharu Tsutsumi
Chiharu Tsutsumi
KUKiichi Unoda
Kiichi Unoda
HKHaruko Kitaoka
Haruko Kitaoka

1 November 2004 in European Neurology
Verified
Journal Article
Closed access
PDF file
HNHideto Nakajima
Hideto Nakajima
KFKazuhiro Fukuda
Kazuhiro Fukuda
YDYoshimitsu Doi
Yoshimitsu Doi
MSMasakazu Sugino
Masakazu Sugino
FKFumiharu Kimura
Fumiharu Kimura
ASAkira Shimizu
Akira Shimizu
Th1 cells play an important role in the pathogenesis of multiple sclerosis (MS), a disease likely linked to an autoimmune process. We measured the levels of chemokines in serum or cerebrospinal fluid (CSF) samples by ELISA, and also studied the expression of Th1-related CXCR3/CCR5 chemokine receptors and Th2-related CCR4/CCR3 chemokine receptors on blood cells from MS patients using three-color flow cytometry. The Bonferroni correction was used for the statistical analysis. The levels of CXCL10, CCL3, and CCL5 in the CSF samples for the MS groups were significantly higher than those for the control group. However, the levels of CCL2 in both the CSF and serum samples for the remission group were significantly higher than those for the active group. The percentage of CXCR3-expressing CD4+ T cells in patients with MS was significantly elevated compared with the healthy controls. Moreover, MS patients in an active phase showed a more increased CD4+CXCR3+/CD4+CCR4+ ratio than patients in a remission phase. The increased percentage of CD4+CXCR3+ cells in the blood was associated with relapses in MS. This study suggested that the CD4+CXCR3+/CD4+CCR4+ ratio could be a sensitive maker of immune dysfunction in MS.